Home/ Supplements/ Niacin/ MetaboBOOST

MetaboBOOST

product on market Softgel Capsule Wonder Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 14% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The product contains niacin and proprietary blends designed for metabolic support and energy. Research provides moderate evidence that niacin supports cellular energy production, while evidence for specific proprietary blends is often limited. The overall evidence coverage for this ingredient profile is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for MetaboBOOST
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
135
Servings
Other Combinations
Product Type
14%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s)
14 mg (70% DV)
Within RDA (1.0× RDA) 196 studies (A:5, B:63)
Burn Blend
426 mg
Amped Blend
819 mg
Melt Blend
269 mg
Activation Blend
62 mg

Other Ingredients

Gelatin Vegetable Glycerin yellow Beeswax
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

For adults, in the morning take 2 softgels before eating or exercising and in the mid afternoon take 2 more softgels. Take 2 softgels twice daily. Do not exceed 2 softgels more often than every four hours. Limit use to no more than 4 softgels in a 24-hour period. If you weigh less than 150 pounds, start with half the suggested amount for the first week (one softgel two times daily).

Do not exceed recommended dose.

Warnings & Precautions

Keep out of reach of children.

Tamper Evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Warning: Keep out of reach of children. Warning: Not for use by individuals under the age of 18 or pregnant or lactating women.

Warning: Not for use by individuals under the age of 18 or pregnant or lactating women.

Do not exceed recommended dose. Increasing frequency of intake will not improve results and may cause adverse reactions.

If you are taking any medications, planning any medical or surgical procedure or have any medical condition, consult your doctor before use.

Avoid this product if you are allergic to aspirin, if you have liver or kidney disease, or high blood pressure.

Avoid this product if you are allergic to aspirin, if you have liver or kidney disease, or high blood pressure. Discontinue use and consult your doctor if any adverse reactions occur.

This product contains caffeine.

Avoid additional consumption of caffeine, which may intensify adverse effects. IP6 (inositol hexaphosphate) can interfere with mineral absorption and should be taken at a different time than mineral-containing supplements.

Contains soy ingredients.

Formulation Notes

Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs) Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.

Made in USA

Natural herbs-ephedra free!

Ephedra free

Herbal thermogenic formula to boost your energy and enhance your diet.

Gluten free

Additional Information

Keep tightly closed. Store at room temperature: 59 degrees-86 degrees F (15 degrees-30 degrees C).

Formula 476

Metadata

Product Details

DSLD Entry Date2021-12-18
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID262492
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.